The Taiwan Food and Drug Administration (TFDA) announced Wednesday that two measures have been implemented to increase intravenous (IV) fluid supplies after a halt in production by Taiwan's major saline supplier sparked concerns about a shortage of the medical resource crucial for surgery.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open higher
09/16/2026 09:11 AM - Politics
- Sports
Gymnastics chief dismissed after denying duo World spots
09/15/2026 09:25 PM - Politics
Labor minister stresses 'reciprocal dignity' ahead of China APEC meeting
09/15/2026 09:19 PM - Society
NT$1M reward offered for information leading to arrest of fugitive aide
09/15/2026 09:12 PM